Julie A Kish
Overview
Explore the profile of Julie A Kish including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
1951
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mell L, Torres-Saavedra P, Wong S, Kish J, Chang S, Jordan R, et al.
Lancet Oncol
. 2024 Nov;
25(12):1576-1588.
PMID: 39551064
Background: Management of patients with locoregionally advanced head and neck squamous cell carcinoma (HNSCC) when cisplatin is contraindicated is controversial. We aimed to assess whether radiotherapy with concurrent and adjuvant...
2.
Extermann M, Al-Jumayli M, Sam C, Kish J
Gerontology
. 2023 Jun;
69(9):1045-1055.
PMID: 37321185
Cancer is a disease of aging and is rapidly becoming the number one cause of mortality in older people. Over their lifetime, one in two men and one in three...
3.
Kirtane K, Hoogland A, Li X, Rodriguez Y, Scheel K, Small B, et al.
Head Neck
. 2023 May;
45(7):1761-1771.
PMID: 37141438
Background: Data about patient-reported outcomes (PROs) among patients with head and neck squamous cell carcinoma (HNSCC) treated with immune checkpoint inhibitors are sparse. Our exploratory study evaluated PROs in patients...
4.
Chung C, Li J, Steuer C, Bhateja P, Johnson M, Masannat J, et al.
Clin Cancer Res
. 2022 Mar;
28(11):2329-2338.
PMID: 35344035
Purpose: A phase II multi-institutional clinical trial was conducted to determine overall survival (OS) in patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) treated with...
5.
Kish J, Zhang Q, Langer C, Nguyen-Tan P, Rosenthal D, Weber R, et al.
J Geriatr Oncol
. 2021 Apr;
12(6):937-944.
PMID: 33814339
Purpose: To examine the role age plays in the treatment and prognosis of locally advanced head and neck cancer (LAHNC) treated definitively with radiation alone or combined modality therapy. Methods:...
6.
Chung C, Bonomi M, Steuer C, Li J, Bhateja P, Johnson M, et al.
Cancers (Basel)
. 2021 Apr;
13(5).
PMID: 33803335
We hypothesized the combination of cetuximab and nivolumab would improve survival in recurrent and/or metastatic (R/M) HNSCC by providing synergy in cancer control and evaluated toxicities and efficacy of the...
7.
Naghavi A, Echevarria M, Strom T, Abuodeh Y, Venkat P, Ahmed K, et al.
Cancer Med
. 2018 Sep;
7(10):4964-4979.
PMID: 30175512
Background: Studies suggest treatment outcomes may vary between high (HVC)- and low-volume centers (LVC). Radiation therapy (RT) for head and neck cancer (HNC) requires weeks of treatment, the inconvenience of...
8.
Dougoud-Chauvin V, Lee J, Santos E, Williams V, Battisti N, Ghia K, et al.
J Geriatr Oncol
. 2018 Apr;
9(6):665-672.
PMID: 29678669
Objective: Big Data is widely seen as a major opportunity for progress in the practice of personalized medicine, attracting the attention from medical societies and presidential teams alike as it...
9.
Ma B, Lim W, Goh B, Hui E, Lo K, Pettinger A, et al.
J Clin Oncol
. 2018 Mar;
36(14):1412-1418.
PMID: 29584545
Purpose This multinational study evaluated the antitumor activity of nivolumab in nasopharyngeal carcinoma (NPC). Tumor and plasma-based biomarkers were investigated in an exploratory analysis. Patients and Methods Patients with multiply...
10.
Maggiore R, Zumsteg Z, BrintzenhofeSzoc K, Trevino K, Gajra A, Korc-Grodzicki B, et al.
Int J Radiat Oncol Biol Phys
. 2017 Jun;
98(4):868-883.
PMID: 28602414
Older adults with head and neck squamous cell carcinoma (HNSCC) pose unique treatment and supportive care challenges to oncologists and other cancer care providers. The majority of patients with HNSCC...